SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EYDY Impairment detection technology

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MakeMoney who wrote (178)6/2/1999 10:18:00 PM
From: Jon Campbell  Read Replies (1) of 215
 
By: Patsy
Reply To: None Wednesday, 2 Jun 1999 at 9:52 PM EDT
Post # of 223


News release inside to be released tomorrow 6-3-99
FOR RELEASE AT 9:00 AM EDT JUNE 3, 1999

Symbol: EYDY OTC/BB

EYE DYNAMICS REPORTS
GOVERNMENTAL TALKS
REGARDING ACCEPTANCE OF EPS-100

Torrance, CA-Charles Phillips, President of Eye Dynamics, announced today
that talks have been held at significant government levels concerning possible
acceptance of its EPS-100 System. These talks are part of the Company's
aggressive presentment of the product to encourage and accelerate adoption
of the EPS-100 by relevant government agencies. The EPS-100 is used to
detect impairment of a person's visual motor system, as is typically caused by
excessive use of alcohol and other substances, both legal and illegal. The
Company is seeking mandatory acceptance of the EPS-100 by various testing
authorities.

The overall potential market for the EPS-100 is estimated at $3 billion
annually. The law enforcement testing market, estimated at $1 billion, centers
around drunk driving, which accounts for about one-half of the 45,000 annual
traffic fatalities. And, with 10% of the U.S. work force testing positive for
substance abuse according to the Department of Labor, the U.S.
corporate/industrial testing market is estimated at $2 billion.

To address these problems, we believe the EPS-100 possesses important and
superior features-is faster, cheaper and non-invasive-relative to traditional
substance abuse tests. These attributes were demonstrated in independent
tests in 1997 conducted through Battelle (a research institute) and funded by
the Transportation Research Board, where the detection accuracy rate of the
EPS-100 far outperformed four competitive systems.

Eye Dynamics is in the business of producing and marketing patented
proprietary products and other services for the institutional, medical and
government markets. The Company's website can be found on the world wide
web
at EDI-VNG.COM..

For further information contact:

Charles Phillips, President at (310)328-0477, FAX (310)328-0697

------------------------------------------------------------

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext